Prevalence, burden, and pharmacoeconomics of dry eye disease.
about
In pursuit of objective dry eye screening clinical techniquesAcupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysisPrevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysisMesenchymal stem cells for treating autoimmune dacryoadenitisAzelastine hydrochloride, a dual-acting anti-inflammatory ophthalmic solution, for treatment of allergic conjunctivitisAcupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops).Cost of dry eye treatment in an Asian clinic settingLost to follow-up for appointments in a dedicated dry eye clinicEvaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunctionA Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction.Electrophoresis of tear proteins as a new diagnostic tool for two high risk groups for dry eye: computer users and contact lens wearers.The relationship between clinical signs and dry eye symptoms.Correlations between eyelid tumors and tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women.Cyclosporine 0.05% ophthalmic emulsion for dry eye in Korea: a prospective, multicenter, open-label, surveillance studyMesenchymal stem/stromal cells protect the ocular surface by suppressing inflammation in an experimental dry eye.Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness.Corneal sensitivity following lacrimal gland excision in the rat.Variability of Tear Osmolarity in Patients With Dry Eye.A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma.Interaction of clusterin and matrix metalloproteinase-9 and its implication for epithelial homeostasis and inflammation.Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial CellsAnnual direct cost of dry eye in Japan.Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women.Effect of Oral Lactoferrin on Cataract Surgery Induced Dry Eye: A Randomised Controlled Trial.Impact of dry eye on work productivityHow to promote and preserve eyelid healthA single-center study evaluating the effect of the controlled adverse environment (CAE(SM)) model on tear film stabilityAccelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic MembraneAutoimmunity at the ocular surface: pathogenesis and regulation.Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress.Dry eye disease and microbial keratitis: is there a connection?Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective studySeverity of dry eye syndrome is related to anti-dsDNA autoantibody in systemic lupus erythematosus patients without secondary Sjogren syndrome: A cross-sectional analysis.A field test of Web-based screening for dry eye disease to enhance awareness of eye problems among general Internet users: a latent strategy to promote health.Etiology, prevalence, and treatment of dry eye disease.Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography.Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up.Discordant Dry Eye Disease (An American Ophthalmological Society Thesis).Interferon-gamma deficiency protects against aging-related goblet cell loss.
P2860
Q26771221-643EFDA7-D637-46F8-BFAD-DE20C0FFE88FQ26863317-7327F7AD-97E9-4971-8053-BA4BCFA4857EQ28073073-6BE3DB45-7408-467E-AD07-F7374F4C51C8Q33768081-65A35E02-D084-450C-B7B6-B02D0DD940B1Q34122907-80FC02E2-F8F4-4591-A132-F9600E1E0C53Q34277339-AAA6717A-6488-4DB2-B99E-4BAA748F0902Q34305185-F371D328-E4DF-4966-B06A-6B6DECE0C242Q34352348-5B202B02-E354-49FA-9631-4D8F807FECD0Q34352815-67C817C6-4DE7-4B9D-8CAE-3A286EE71315Q34627003-1A4C7AE6-5339-45F6-B0A7-C340D419C179Q35201781-19A74612-DE1F-4EF4-BF1D-80F399C99228Q35208749-29AF2890-DE8C-4E35-A66C-48066479D0D6Q35422889-8544AA98-8AB9-475F-BFB7-E765C41777EEQ35572113-0C1B3511-A41A-47F9-A123-646C48FF4E42Q35591394-69D27B62-19DC-41C5-A60D-9CB9D60C139AQ35632214-D77B990C-FA81-42DB-9587-DDD07E2BF8DAQ35678783-CDC2341C-1FA2-4571-95A8-C8AE599649FEQ35738567-9145307F-95BF-46EA-9F21-97E6BC994BD5Q35906365-A53F0906-F6F5-42E3-ABAE-35B7C01396F0Q35951860-DE3D2C88-BF11-4690-BE34-D8D7C17F1F42Q35979980-04541A25-02DC-42A0-A342-791026723504Q35997499-3ADF4F31-4546-48D3-8F86-E440D6E8CDF5Q36041432-74DD8C9D-D7CB-4133-8C82-53C2AE6B8115Q36222021-B7674BE3-6F17-4B8E-B217-E2C065F9BB44Q36317967-D06325FD-8D5C-43F8-997C-D9E0C054F85DQ36358739-34C776E8-BE87-4804-AA0C-2542F94ADF19Q36410618-6172BE5A-DBFA-4FF3-B570-EB9DD886105CQ36445561-427AA1A1-BA13-45AE-B495-0F13A81E6309Q36625074-54BB4A92-F6B0-4DB2-A1EF-2F4C334BAFDEQ36692399-A66CA582-0CC5-4F9E-BAD9-3EFB58779C20Q36799601-02815E7F-EBB4-4B74-BBF4-1149D1A58C51Q36872927-8AF6FBE6-571E-42B6-9201-23FFD8368F3BQ36931629-0712E42C-0779-4118-AB75-7D0C6F01C2F9Q37116902-08A68310-1D09-43DD-A896-DB6861A756B5Q37204567-366E0CA0-29E5-4C1C-BFAC-5A1B790C1BDFQ37288773-0B0C3A35-36E1-498A-8CD2-565BC5763F31Q37397701-02B78971-088C-43A5-9F01-BDDD63B33CAAQ37471561-0C13101E-AD30-4F71-A03B-5AFD0CF41569Q37536295-8BF3008E-C6A4-4C3A-888B-4F944729A535Q37662097-480F9156-1E68-432C-A4A4-00FCD9C2E941
P2860
Prevalence, burden, and pharmacoeconomics of dry eye disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@en
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@nl
type
label
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@en
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@nl
prefLabel
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@en
Prevalence, burden, and pharmacoeconomics of dry eye disease.
@nl
P1476
Prevalence, burden, and pharmacoeconomics of dry eye disease
@en
P2093
Stephen C Pflugfelder
P304
P433
P577
2008-04-01T00:00:00Z